# Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults

> **NCT03722472** · PHASE1 · COMPLETED · sponsor: **Access to Advanced Health Institute (AAHI)** · enrollment: 48 (actual)

## Conditions studied

- Pulmonary TB

## Interventions

- **BIOLOGICAL:** ID93 + GLA-SE

## Key facts

- **NCT ID:** NCT03722472
- **Lead sponsor:** Access to Advanced Health Institute (AAHI)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-02
- **Primary completion:** 2020-06-15
- **Final completion:** 2020-06-15
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-06-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03722472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03722472, "Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03722472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*